Mustang Bio Stock Cash Flow From Operations
| MBIO Stock | USD 0.32 0.03 8.57% |
Mustang Bio fundamentals help investors to digest information that contributes to Mustang Bio's financial success or failures. It also enables traders to predict the movement of Mustang Stock. The fundamental analysis module provides a way to measure Mustang Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mustang Bio stock.
Mustang | Cash Flow From Operations |
Mustang Bio Company Cash Flow From Operations Analysis
Mustang Bio's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Mustang Bio Cash Flow From Operations | (49.48 M) |
Most of Mustang Bio's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mustang Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Mustang Cash Flow From Operations Driver Correlations
Understanding the fundamental principles of building solid financial models for Mustang Bio is extremely important. It helps to project a fair market value of Mustang Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since Mustang Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mustang Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mustang Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Mustang Bio has (49.48 Million) in Cash Flow From Operations. This is 109.38% lower than that of the Biotechnology sector and 179.13% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 105.09% higher than that of the company.
Mustang Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mustang Bio's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mustang Bio could also be used in its relative valuation, which is a method of valuing Mustang Bio by comparing valuation metrics of similar companies.Mustang Bio is currently under evaluation in cash flow from operations category among related companies.
Mustang Fundamentals
| Return On Equity | -2.22 | ||||
| Return On Asset | -0.58 | ||||
| Current Valuation | (117.97 K) | ||||
| Shares Outstanding | 9.54 M | ||||
| Shares Owned By Insiders | 22.76 % | ||||
| Shares Owned By Institutions | 10.10 % | ||||
| Number Of Shares Shorted | 136.52 K | ||||
| Price To Earning | (11.40) X | ||||
| Price To Book | 42.91 X | ||||
| EBITDA | (48.5 M) | ||||
| Net Income | (51.6 M) | ||||
| Cash And Equivalents | 107.37 M | ||||
| Cash Per Share | 1.01 X | ||||
| Total Debt | 2.5 M | ||||
| Debt To Equity | 0.35 % | ||||
| Current Ratio | 9.96 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (49.48 M) | ||||
| Short Ratio | 0.56 X | ||||
| Earnings Per Share | (6.00) X | ||||
| Target Price | 17.5 | ||||
| Number Of Employees | 80 | ||||
| Beta | 1.54 | ||||
| Market Capitalization | 3.28 M | ||||
| Total Asset | 17.74 M | ||||
| Retained Earnings | (380.97 M) | ||||
| Working Capital | (4.03 M) | ||||
| Current Asset | 42.37 M | ||||
| Current Liabilities | 3.93 M | ||||
| Net Asset | 17.74 M |
About Mustang Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mustang Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mustang Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mustang Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mustang Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mustang Bio's short interest history, or implied volatility extrapolated from Mustang Bio options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Mustang Bio Piotroski F Score and Mustang Bio Altman Z Score analysis. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Mustang Stock analysis
When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.00) | Revenue Per Share (0) | Return On Assets (0.58) | Return On Equity (2.22) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.